| Oct 24 |
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
|
| Oct 23 |
Him & Hers, WW down on Novo attempt to restrict compounded semaglutide
|
| Oct 22 |
Define Ventures Appoints Bruce Broussard as Venture Partner
|
| Oct 21 |
Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug
|
| Oct 21 |
Hims & Hers Health names Jessica Shepherd as chief medical officer
|
| Oct 21 |
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
|
| Oct 19 |
FDA not planning to take action against GLP-1 compounders, Endpoints says
|
| Oct 17 |
HIMS: GLP-1 Is Just The Beginning
|
| Oct 17 |
3 US Growth Companies With Significant Insider Ownership
|
| Oct 16 |
Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.
|
